Gene expression data from Orthotopic human immune system reconstituted (HIR) patient-derived xenograft (PDX) PDAC mouse models treated with Ladarixin, Nivolumab, and the combination of the two drugs

Published: 4 October 2022| Version 1 | DOI: 10.17632/v92gyrfcwd.1
Contributor:

Description

RNA-seq raw count matrix from Orthotopic human immune system reconstituted (HIR) patient-derived xenograft (PDX) PDAC mouse models. metadata file match sample IDs and treatment conditions

Files

Steps to reproduce

Tumor tissue was collected from from Orthotopic human immune system reconstituted (HIR) patient-derived xenograft (PDX) PDAC mouse model for RNAsequencing. RNA integrity number (RIN) was measured on an Agilent Bio Analyzer 2100 system. Only RNA samples with a RIN > 7 were used for cDNA library construction. All cDNA libraries were sequenced using paired-end strategy (read length 150 bp) on an Illumina HiSeq 2000 platform. Quality of raw reads was checked with FASTQC. Transcripts were quantified with the alignment-free method implemented in Salmon 0.11.3. Mouse genome and transcriptome from Genecode Release M18 (GRCm38.p6) were used. ### Note for the paper data Differential expression analysis was performed with NOISeq R package Gene Set Enrichment analysis of deregulated genes was performed using enrichR package

Institutions

Universita Cattolica del Sacro Cuore

Categories

Oncology, RNA Sequencing, Immunotherapy

Licence